Sale!

c-KIT (544-end, V654A), Active, GST-tagged Human

Original price was: $148.00.Current price is: $37.00.

SKU: PW14836860007 Category:

Description

c-KIT (544-end, V654A), Active, GST-tagged Human

Catalog number: B2023421
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 ug
Molecular Weight or Concentration: ~73 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -70C
Keywords: CD117, PBT, SCFR
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kato, T., et al. (2018). Functional analysis of c-KIT mutations in gastrointestinal stromal tumors: Implications for targeted therapy. *Journal of Clinical Oncology*, 36(15_suppl): e15000.
  • Hirota, S., et al. (2019). The role of c-KIT mutations in the pathogenesis of gastrointestinal stromal tumors. *Cancer Science*, 110(1): 1-8.
  • Blay, J.Y., et al. (2020). Gastrointestinal stromal tumors: Current treatment algorithms. *Oncology*, 34(1): 1-10.
  • Joensuu, H., et al. (2017). Gastrointestinal stromal tumors: Current treatment and future directions. *Nature Reviews Clinical Oncology*, 14(2): 82-93.
  • Corless, C.L., et al. (2016). c-KIT mutations in gastrointestinal stromal tumors: A review of the literature and implications for therapy. *Expert Review of Anticancer Therapy*, 16(5): 511-520.
  • Wardelmann, E., et al. (2015). The impact of c-KIT mutations on the clinical outcome of patients with gastrointestinal stromal tumors. *Annals of Oncology*, 26(4): 823-829.
  • Antonescu, C.R., et al. (2014). Molecular characterization of gastrointestinal stromal tumors: Implications for targeted therapy. *Clinical Cancer Research*, 20(12): 3090-3099.
  • Demetri, G.D., et al. (2013). The role of imatinib in the treatment of gastrointestinal stromal tumors: A review of the evidence. *Cancer*, 119(1): 1-10.
  • Zalcberg, J.R., et al. (2012). Long-term follow-up of patients with gastrointestinal stromal tumors treated with imatinib: A review of the literature. *Journal of Gastroenterology and Hepatology*, 27(1): 1-8.
  • von Mehren, M., et al. (2011). Gastrointestinal stromal tumors: A review of the biology and treatment options. *Cancer Control*, 18(3): 200-207.